A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging

European Journal of Pharmacology

Volumn 350, Issue 1, 1998, Pages 75-79

  Hara, Tsutomu ^a   Kusunoki, Masataka ^a   Tsutsumi, Kazuhiko ^b   Okada, Kazuko ^c   Sakamoto, Sadaichi ^c   Ohnaka, Masaharu ^c   Nakamura, Takao ^d   Miyata, Tetsuro ^e   Nakayama, Kaori ^a   Fukatsu, Atsushi ^a   Kato, Katsumi ^a   Kakumu, Shinichi ^a   Nakaya, Yutaka ^c  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b Otsuka Pharmaceutical Factory   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

(Rat, old); Endothelium dependent relaxation; High density lipoprotein cholesterol; Lipoprotein lipase; NO 1886

Indexed keywords

4 [(4 BROMO 2 CYANOPHENYL)CARBAMOYL]BENZYLPHOSPHONIC ACID DIETHYL ESTER; BENZAMIDE DERIVATIVE; HISTAMINE; LIPOPROTEIN LIPASE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

AGING; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; AORTA; ARTERIOSCLEROSIS; BENZAMIDES; BLOOD GLUCOSE; BODY WEIGHT; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; INSULIN; LIPID PEROXIDES; LIPIDS; LIPOPROTEIN LIPASE; MALE; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; VASODILATION;

EID: 0032577681     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00230-1     Document Type: Article

References (29)

1. Andrews H.E., Bruckdorfer K.R., Dunn R.C., Jacobs M. Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:1987;237-239.
2. Austin M.A. Plasma triglyceride and coronary heart disease. Arteroscler. Thromb. 11:1991;2-14.
3. Badimon J.J., Badimon L., Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest. 85:1990;1234-1241.
4. Bossaller C., Habid G.B., Yamamoto H., Williams C., Wells S., Henry P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 3′,5′-monophosphate formation in the atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest. 79:1987;170-174.
5. Chiba T., Miura S., Sawamura F., Uetsuka R., Tomita I., Inoue Y., Tsutsumi K., Tomita T. Antiatherogenic effects of a novel lipoprotein lipase-enhancing agent cholesterol-fed New Zealand white rabbits. Arterioscler. Thromb. Vasc. Biol. 17:1997;2601-2608.
6. Cohen R.A., Zitnay K.M., Haudenschild C.C., Cunningham L.D. Loss of selective endothelial cell vasoactive functions caused by hypercholestrolemia in pig coronary arteries. Circ. Res. 63:1988;903-910.
7. Dohi Y., Thiel M.A., Bler F.R., Luscher T.F. Activation of endothelial L-arginine pathway in resistance arteries: effects of age and hypertension. Hypertension. 15:1990;170-179.
8. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N., Warnet J.M., Claude J.R., Rosselin G.E. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucosefactor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 32:1989;300-304.
9. Freiman R.C., Mitchell G.G., Heistad D.D., Armstrong M.L., Harrison D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primated. Circ. Res. 58:1986;783-789.
10. Hagi, A., Hirai, I., Kohri, H., Tsutsumi, K., 1997. The novel compound NO-1886 activates lipoprotein lipase in primary cultured adipose and skeletal muscle cells. Biol. Pharm. Bull. (in press).
11. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham heart study. Circulation. 67:1983;968-977.
12. Ignarro L.J., Byrns R.E., Buga G.M., Wood K.S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61:1987;866-879.
13. Jayakody L., Senaratne M., Thomson A., Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ. Res. 60:1987;251-264.
14. Kusunoki M., Hara T., Sakakibara F., Chikada K., Usui K., Yamanouchi K., Nakaya Y., Kakumu S., Storlien L.H. The novel lipoprotein lipase (LPL) activating compound NO-1886 prevents weight gain in high-fat fed NIDDM model rats. Diabetologia. 40:1997;704. (Suppl.)A-180.
15. Lakatta E.G., Yin F.C.P. Myocardial aging, functional alterations and related cellular mechanisms. Am. J. Physiol. 242:1982;H927-941. Heart Circ. Physiol. 11.
16. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1986;1046-1051.
17. Mayhan W.G., Faraci F.M., Baumbach G.L., Heistad D.D. Effects of aging on responses of cerebral arterioles. Am. J. Physiol. 258:1990;H1138-1143. Heart Circ. Physiol. 27.
18. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein and 244 erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
19. Moritoki H., Hosoki E., Ishida Y. Age-related decrease in endothelium-dependent dilator response to histamine in rat mesenteric artery. Eur. J. Pharmacol. 126:1986;61-67.
20. Moritoki H., Tanioka A., Maeshiba Y., Iwamoto T., Ishida Y., Araki H. Age-associated decrease in histamine-induced vasodilatation may be due to reduction of cyclic GMP formation. Br. J. Pharmacol. 95:1988;1015-1022.
21. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
22. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
23. Shimokawa H., Vanhoutte P.M. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolaemia and atherosclerosis. Circ. Res. 64:1989;900-914.
24. Tsutsumi K., Inoue Y., Shima A., Iwasaki K., Kawamura M., Murase T. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J. Clin. Invest. 92:1993;411-417.
25. Tsutsumi K., Inoue Y., Shima A., Murase T. Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes. 44:1995;414-417.
26. Vanhoutte P.M., Rubanyi G.M., Miller V.M., Houston D.S. Modulation of vascular smooth muscle contraction by the endothelium. Annu. Rev. Physiol. 48:1986;307-320.
27. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van-Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit: I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ. Res. 58:1986;552-564.
28. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
29. Yamamoto Y., Tomoike H., Egashira K., Nakamura M. Attenuation of endothelium-related relaxation and enhanced responsiveness of vascular smooth muscle to histamine in spastic coronary arterial segments from miniature pigs. Circ. Res. 61:1987;772-778.